Comments to OEHHA: Fluroide Hazard Identification Materials Share page: This letter sets forth the scientific and regulatory reasons that fluoride does not meet the Proposition 65 criteria for listing. Download Document Issues: OTC Medicines Fluoride Related Posts Press Releases and Statements CHPA Applauds White House Executive Order Prioritizing Lower Drug Costs and Access to Self-Care Apr 17, 2025 Press Releases and Statements CHPA Responds to Section 232 Investigation on Pharmaceuticals Apr 15, 2025 Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025